Search

Filters
Clear All
  • 20

Phase

  • 1
  • 1
  • 4
  • 10
  • 4
  • 20
  • 18

Found 20 sandeep-batra-md trials

A listing of sandeep-batra-md medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

S
Sandeep Batra, MD
21 or below
All genders
What is the purpose of this study?This clinical trial studies cancer survivors to identify those who are at increased risk of developing late-occurring complications after undergoing treatment for childhood cancer. A patient's genes may affect the risk of developing complications, such as congestive heart failure, avascular necrosis, stroke, and second …
S
Sandeep Batra, MD
1 - 25
All genders
What is the purpose of this study?This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent …
S
Sandeep Batra, MD
49 or below
All genders
Phase 3
What is the purpose of this study?This phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. …
S
Sandeep Batra, MD
8 - 15
All genders
What is the purpose of this study?This randomized clinical trial studies how well web-based physical activity intervention works in improving long term health in children and adolescents with newly diagnosed acute lymphoblastic leukemia that shows a decrease in or disappearance of signs and symptoms. Regular physical activity after receiving treatment …
S
Sandeep Batra, MD
1 - 21
All genders
Phase 2
What is the purpose of this study?This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or …
S
Sandeep Batra, MD
1 - 21
All genders
Phase 2
What is the purpose of this study?This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with B-lymphoblastic lymphoma or CD22 positive B acute lymphoblastic leukemia that has come back (relapsed) or does not respond to treatment (refractory). Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, …
S
Sandeep Batra, MD
4 - 17
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares memantine to usual treatment in treating patients with primary central nervous system tumors. Memantine may block receptors (parts of nerve cells) in the brain known to contribute to a decline in cognitive function. Giving memantine may make a difference …
S
Sandeep Batra, MD
1 - 50
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial compares the effect of open thoracic surgery (thoracotomy) tohoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgeryype of surgery done through a single larger incision (like …
S
Sandeep Batra, MD
3 - 21
All genders
Phase 3
Interventional
What is the purpose of this study?This phase III trial tests two hypotheses in patients with low-risk and average-riskdulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back after treatment. Subjects withw-risk medulloblastoma …
S
Sandeep Batra, MD
1 - 21
All genders
Phase 3
Interventional
What is the purpose of this study?Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phaseutcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristined dactinomycin (VA) and examines the use …
1 - 10 of 20